5‐Aminolevulinic acid‐based photodynamic therapy
暂无分享,去创建一个
Q. Peng | K. Berg | J. Moan | M. Kongshaug | J. Nesland | K. Giercksky | T. Warloe
[1] P. Mustajoki,et al. Hereditary hepatic porphyrias in Finland. , 2009, Acta medica Scandinavica.
[2] Joris Kloek,et al. Derivatives of 5‐Aminolevulinic Acid for Photodynamic Therapy: Enzymatic Conversion into Protoporphyrin , 1998, Photochemistry and photobiology.
[3] H Anholt,et al. Use of 5-aminolevulinic acid esters to improve photodynamic therapy on cells in culture. , 1997, Cancer research.
[4] Q. Peng,et al. 5‐Aminolevulinic Acid‐Based Photodynamic Therapy: Principles and Experimental Research , 1997, Photochemistry and photobiology.
[5] J Moan,et al. Pharmacokinetic studies on 5-aminolevulinic acid-induced protoporphyrin IX accumulation in tumours and normal tissues. , 1997, Cancer letters.
[6] Joris Kloek,et al. Prodrugs of 5‐Aminolevullinic Acid for Photodynamic Therapy , 1996, Photochemistry and photobiology.
[7] A. Oseroff,et al. ALA-PDT in dermatology Results and mechanisms , 1996 .
[8] G. Stables,et al. The accumulation of protoporphyrin IX in plaque psoriasis after topical application of 5-aminolevulinic acid indicates a potential for superficial photodynamic therapy. , 1996, The Journal of investigative dermatology.
[9] D. Kessel,et al. Feasibility of photodynamic therapy using endogenous photosensitization for colon cancer. , 1996, Archives of surgery.
[10] P Baas,et al. Photodynamic therapy: a promising new modality for the treatment of cancer. , 1996, Journal of photochemistry and photobiology. B, Biology.
[11] J Moan,et al. Build-up of esterified aminolevulinic-acid-derivative-induced porphyrin fluorescence in normal mouse skin. , 1996, Journal of Photochemistry and Photobiology. B: Biology.
[12] CLAUDE C. FRAZIER,et al. PHOTODYNAMIC THERAPY IN DERMATOLOGY , 1996, International journal of dermatology.
[13] S. C. Chang,et al. Photodynamic therapy on rat urinary bladder with intravesical instillation of 5-aminolevulinic acid: light diffusion and histological changes. , 1996, The Journal of urology.
[14] S. C. Chang,et al. Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid. , 1996, The Journal of urology.
[15] R Baumgartner,et al. Early clinical experience with 5-aminolevulinic acid for the photodynamic therapy of superficial bladder cancer. , 1996, British journal of urology.
[16] Berry Jp. The role of lysosomes in the selective concentration of mineral elements. A microanalytical study. , 1996 .
[17] M W Berns,et al. Selective photosensitizer distribution in vulvar condyloma acuminatum after topical application of 5-aminolevulinic acid. , 1996, American journal of obstetrics and gynecology.
[18] R. G. Frank,et al. Photodynamic therapy for condylomata acuminata with local application of 5-aminolevulinic acid. , 1996, Genitourinary medicine.
[19] Qian Peng,et al. Photodegradation of sensitizers in mouse skin during PCT , 1996, European Conference on Biomedical Optics.
[20] Julia G. Levy,et al. Clinical status of benzoporphyrin derivative , 1996, European Conference on Biomedical Optics.
[21] Martin J. C. van Gemert,et al. Whole bladder wall photodynamic therapy using 5-ALA: an experimental study in pigs , 1996, European Conference on Biomedical Optics.
[22] James C. Kennedy,et al. Photodynamic therapy with 5-aminolevulinic acid: basic principles and applications , 1996, European Conference on Biomedical Optics.
[23] Johan Emelian Moan,et al. Choice of the proper wavelength for photochemotherapy , 1996, European Conference on Biomedical Optics.
[24] J Moan,et al. DISTRIBUTION OF 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRINS IN NODULOULCERATIVE BASAL CELL CARCINOMA , 1995, Photochemistry and photobiology.
[25] M. Dilkes. JLO Travelling Fellowship 1994 Report , 1995, The Journal of Laryngology & Otology.
[26] G. Kenyon,et al. Treatment of head and neck cancer with photodynamic therapy: results after one year , 1995, The Journal of Laryngology & Otology.
[27] A. Goetz,et al. Wavelength dependency of photodynamic effects after sensitization with 5-aminolevulinic acid in vitro and in vivo. , 1995, The Journal of investigative dermatology.
[28] B. Henderson,et al. PHOTOSENSITIZATION OF MURINE TUMOR, VASCULATURE and SKIN BY 5‐AMINOLEVULINIC ACID‐INDUCED PORPHYRIN , 1995, Photochemistry and photobiology.
[29] B. Steinberg,et al. Efficacy of intravenous delta-aminolaevulinic acid photodynamic therapy on rabbit papillomas. , 1995, British Journal of Cancer.
[30] M. Stringer. Problems associated with the use of broad-band illumination sources for photodynamic therapy. , 1995, Physics in medicine and biology.
[31] T. Hunziker,et al. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. , 1995, Journal of the American Academy of Dermatology.
[32] Q. Peng,et al. Correlation of distribution of sulphonated aluminium phthalocyanines with their photodynamic effect in tumour and skin of mice bearing CaD2 mammary carcinoma. , 1995, British Journal of Cancer.
[33] H. Hönigsmann,et al. Photodynamic therapy of epithelial skin tumours using delta‐aminolaevulinic acid and desferrioxamine , 1995, The British journal of dermatology.
[34] Z. Malik,et al. Temperature monitoring during photodynamic therapy of skin tumors with topical 5-aminolevulinic acid application. , 1995, Cancer letters.
[35] H. Kerl,et al. Photodynamic therapy with 5-aminolevulinic acid: a promising concept for the treatment of cutaneous tumors. , 1995, Dermatology.
[36] R. Pottier,et al. On the role of protoporphyrin IX photoproducts in photodynamic therapy. , 1995, Journal of photochemistry and photobiology. B, Biology.
[37] A. Spigelman,et al. Photodynamic therapy for polyps in familial adenomatous polyposis--a pilot study. , 1995, European journal of cancer.
[38] P. Calzavara-Pinton,et al. Repetitive photodynamic therapy with topical delta-aminolaevulinic acid as an appropriate approach to the routine treatment of superficial non-melanoma skin tumours. , 1995, Journal of photochemistry and photobiology. B, Biology.
[39] Q. Peng,et al. Uptake, localization, and photodynamic effect of meso-tetra(hydroxyphenyl)porphine and its corresponding chlorin in normal and tumor tissues of mice bearing mammary carcinoma. , 1995, Cancer research.
[40] R. Anderson,et al. Photodynamic therapy of nonmelanoma skin cancer with topical aminolevulinic acid: a clinical and histologic study. , 1995, Archives of dermatology.
[41] M. Kotler,et al. High δ-aminolevulinic acid uptake in rat cerebral cortex: effect on porphyrin biosynthesis , 1995 .
[42] A. Oseroff,et al. THE ROLE OF TRANSFERRIN RECEPTOR (CD71) IN PHOTODYNAMIC THERAPY OF ACTIVATED AND MALIGNANT LYMPHOCYTES USING THE HEME PRECURSOR δ‐AMINOLEVULINIC ACID (ALA) , 1995, Photochemistry and photobiology.
[43] T. Foster,et al. Effectiveness of delta-aminolevulinic acid-induced protoporphyrin as a photosensitizer for photodynamic therapy in vivo. , 1995, Cancer research.
[44] Stefan Andersson-Engels,et al. Pharmacokinetic studies of δ-aminolevulinic-acid-induced protoporphyrin IX build-up in some malignant tumors , 1995, Photonics West.
[45] R. Desnick,et al. Uroporphyrinogen-III synthase: molecular cloning, nucleotide sequence, expression of a mouse full-length cDNA, and its localization on mouse chromosome 7. , 1995, Genomics.
[46] T. Hasan,et al. Investigative Urology: Biodistribution and Phototoxicity of 5-Aminolevulinic Acid-Induced PpIX in an Orthotopic Rat Bladder Tumor Model , 1995 .
[47] Benjamin Ehrenberg,et al. Photodynamic therapy of human skin tumors using topical application of 5-aminolevulinic acid, dimethylsulfoxide (DMSO), and edetic acid disodium salt (EDTA) , 1995, Other Conferences.
[48] Kristian Berg,et al. Photomodification of ALA-induced protoporphyrin IX in cells in vitro , 1995, Other Conferences.
[49] Qian Peng,et al. Photodynamic therapy of human tubulo-villous adenomas , 1995, Other Conferences.
[50] Sabine Mai,et al. The c-myc protein represses the lambda 5 and TdT initiators , 1995, Nucleic Acids Res..
[51] A Gorchein,et al. Photosensitisation and photodynamic therapy of oesophageal, duodenal, and colorectal tumours using 5 aminolaevulinic acid induced protoporphyrin IX--a pilot study. , 1995, Gut.
[52] R Baumgartner,et al. Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid. , 1994, Urology.
[53] W. Cheong,et al. Photoproduct formation during irradiation of tissues containing protoporphyrin. , 1994, Journal of photochemistry and photobiology. B, Biology.
[54] R Baumgartner,et al. Intravesical instillation of 5-aminolevulinic acid: the fluorescent metabolite is limited to urothelial cells. , 1994, Urology.
[55] Stanley B. Brown,et al. Distribution of protoporphyrin IX in Bowen's disease and basal cell carcinomas treated with topical 5-aminolaevulinic acid , 1994, Other Conferences.
[56] Johan Emelian Moan,et al. Measurements of sensitizer fluorescence in patients by means of an ordinary fluorescence spectrometer , 1994, Other Conferences.
[57] Harald B. Steen,et al. Photodynamic therapy with 5-aminoolevulinic acid-induced porphyrins and DMSO/EDTA for basal cell carcinoma , 1994, Other Conferences.
[58] H. Kerl,et al. Photodynamic therapy for mycosis fungoides after topical photosensitization with 5-aminolevulinic acid. , 1994, Journal of the American Academy of Dermatology.
[59] H. Bonkovsky,et al. Differential effects of metalloporphyrins on messenger RNA levels of delta-aminolevulinate synthase and heme oxygenase. Studies in cultured chick embryo liver cells. , 1994, The Journal of clinical investigation.
[60] N. Brown,et al. Kinetics of endogenous protoporphyrin IX induction by aminolevulinic acid: preliminary studies in the bladder. , 1994, The Journal of urology.
[61] J. Reguła,et al. Photodynamic therapy using 5-aminolaevulinic acid for experimental pancreatic cancer--prolonged animal survival. , 1994, British Journal of Cancer.
[62] A. Batlle,et al. Porphyrinogenesis in rat cerebellum. Effect of high δ-aminolevulinic acid concentration , 1994 .
[63] K Svanberg,et al. Photodynamic therapy of non‐melanoma malignant tumours of the skin using topical δ‐amino levulinic acid sensitization and laser irradiation , 1994, The British journal of dermatology.
[64] W. Sterry,et al. Treatment of psoriasis by topical photodynamic therapy with polychromatic light , 1994, The Lancet.
[65] R. Rox Anderson,et al. Photodynamic therapy of malignancies with benzoporphyrin derivative monoacid ring A , 1994, Other Conferences.
[66] D. V. Ash,et al. Superficial photodynamic therapy with topical 5-aminolaevulinic acid for superficial primary and secondary skin cancer. , 1994, British Journal of Cancer.
[67] Qian Peng,et al. Dosimetry and light distribution systems for photodynamic therapy at the Norwegian Radium Hospital , 1994, Other Conferences.
[68] M Landthaler,et al. PENETRATION POTENCY OF TOPICAL APPLIED δ‐AMINOLEVULINIC ACID FOR PHOTODYNAMIC THERAPY OF BASAL CELL CARCINOMA * , 1994, Photochemistry and photobiology.
[69] J. Frisoli,et al. Pharmacokinetics of a fluorescent drug using laser-induced fluorescence. , 1993, Cancer research.
[70] K König,et al. Time-resolved in-vivo fluorescence of photosensitizing porphyrins. , 1993, Journal of photochemistry and photobiology. B, Biology.
[71] S. Bown,et al. Photodynamic Therapy in Gastroenterology - Current Status and Future Prospects , 1993, Endoscopy.
[72] A. Batlle,et al. Porphyrins, porphyrias, cancer and photodynamic therapy--a model for carcinogenesis. , 1993, Journal of photochemistry and photobiology. B, Biology.
[73] D. Vernon,et al. Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract. , 1993, Journal of photochemistry and photobiology. B, Biology.
[74] J. Feyh,et al. Photodynamic laser therapy of basal-cell carcinoma of the lid. , 1993, German journal of ophthalmology.
[75] P. Speight,et al. Photodynamic therapy of oral cancer: photosensitisation with systemic aminolaevulinic acid , 1993, The Lancet.
[76] A. J. MacRobert,et al. Oral versus intravenous administration of 5-aminolaevulinic acid for photodynamic therapy. , 1993, British Journal of Cancer.
[77] K König,et al. In vivo photoproduct formation during PDT with ALA-induced endogenous porphyrins. , 1993, Journal of photochemistry and photobiology. B, Biology.
[78] C. Perez. Nonmelanoma cancers of the skin. , 1993, The New England journal of medicine.
[79] P. Charlesworth,et al. The use of 5-aminolevulinic acid (ALA) in photodynamic therapy (PDT). , 1993, Journal of photochemistry and photobiology. B, Biology.
[80] H. Pass,et al. Photodynamic therapy in oncology: mechanisms and clinical use. , 1993, Journal of the National Cancer Institute.
[81] N. Gray,et al. Translational control of 5-aminolevulinate synthase mRNA by iron-responsive elements in erythroid cells. , 1993, The Journal of biological chemistry.
[82] M. Timko,et al. Regulation by heme of mitochondrial protein transport through a conserved amino acid motif. , 1993, Science.
[83] T. Mang,et al. Photodynamic therapy in the management of neoplasms of the perianal skin. , 1992, Archives of surgery.
[84] R. Anderson,et al. Photodynamic therapy in dermatology. Shedding a different light on skin disease. , 1992 .
[85] Michele T. Cooper,et al. Photodynamic therapy for the treatment of basal cell carcinoma. , 1992, Archives of dermatology.
[86] T. Mang,et al. Photodynamic therapy in the treatment of Bowen's disease. , 1992, Journal of the American Academy of Dermatology.
[87] J Moan,et al. Distribution and photosensitizing efficiency of porphyrins induced by application of exogenous 5‐aminolevulinic acid in mice bearing mammary carcinoma , 1992, International journal of cancer.
[88] N Kollias,et al. Effects of photodynamic therapy with topical application of 5-aminolevulinic acid on normal skin of hairless guinea pigs. , 1992, Journal of photochemistry and photobiology. B, Biology.
[89] R. van Hillegersberg,et al. Selective accumulation of endogenously produced porphyrins in a liver metastasis model in rats. , 1992, Gastroenterology.
[90] J. Kennedy,et al. Endogenous protoporphyrin IX, a clinically useful photosensitizer for photodynamic therapy. , 1992, Journal of photochemistry and photobiology. B, Biology.
[91] A Gorchein,et al. Sustained high plasma 5‐aminolaevulinic acid concentration in a volunteer: no porphyric symptoms , 1992, European journal of clinical investigation.
[92] Dieter Jocham,et al. Photodynamic diagnosis of early stage malignancies: preliminary results in urology and pneumonology , 1992, Photonics West - Lasers and Applications in Science and Engineering.
[93] H. Stepp,et al. PHARMACOKINETICS OF FLUORESCENT POLYPORPHYRIN PHOTOFRIN II IN NORMAL RAT TISSUE AND RAT BLADDER TUMOR , 1992, Photochemistry and photobiology.
[94] M. M. el-Sharabasy,et al. Porphyrin metabolism in some malignant diseases. , 1992, British Journal of Cancer.
[95] P. Sinclair,et al. Heme regulates hepatic 5-aminolevulinate synthase mRNA expression by decreasing mRNA half-life and not by altering its rate of transcription. , 1991, Archives of biochemistry and biophysics.
[96] H. Kerl,et al. Photodynamic therapy in patient with xeroderma pigmentosum , 1991, The Lancet.
[97] C. Rebeiz,et al. TETRAPYRROLE‐DEPENDENT PHOTODYNAMIC HERBICIDES , 1990 .
[98] A. Emmett. Surgical analysis and biological behaviour of 2277 basal cell carcinomas. , 1990, The Australian and New Zealand journal of surgery.
[99] J. Feyh,et al. Photodynamic therapy in head and neck surgery. , 1990, Journal of photochemistry and photobiology. B, Biology.
[100] L. Brady. External irradiation of epithelial skin cancer. , 1990, International journal of radiation oncology, biology, physics.
[101] C. Perez,et al. External irradiation of epithelial skin cancer. , 1990, International journal of radiation oncology, biology, physics.
[102] R Marchesini,et al. Photodynamic therapy by topical meso-tetraphenylporphinesulfonate tetrasodium salt administration in superficial basal cell carcinomas. , 1990, Cancer research.
[103] J. Kennedy,et al. Photodynamic therapy with endogenous protoporphyrin IX: basic principles and present clinical experience. , 1990, Journal of photochemistry and photobiology. B, Biology.
[104] P. Garcia‐Webb,et al. Inhibition of human lymphocyte ferrochelatase activity by hemin. , 1990, Biochimica et biophysica acta.
[105] J C Kennedy,et al. Phototoxic damage to sebaceous glands and hair follicles of mice after systemic administration of 5-aminolevulinic acid correlates with localized protoporphyrin IX fluorescence. , 1990, The American journal of pathology.
[106] J. Lacroix,et al. Neurologic crises in hereditary tyrosinemia. , 1990, The New England journal of medicine.
[107] H Fukuda,et al. Tumor-localizing properties of porphyrins. In vitro studies using the porphyrin precursor, aminolevulinic acid, in free and liposome encapsulated forms. , 1989, Drug design and delivery.
[108] Z. Malik,et al. Inactivation of erythrocytic, lymphocytic and myelocytic leukemic cells by photoexcitation of endogenous porphyrins. , 1989, Journal of photochemistry and photobiology. B, Biology.
[109] J. Carruth,et al. Photodynamic therapy in the treatment of malignant tumours of the skin and head and neck. , 1989, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology.
[110] I. Z. Ades,et al. Regulation of the stability of chicken embryo liver δ-aminolevulinate synthase mRNA by hemin , 1989 .
[111] Mayfield Bk,et al. Control of heme biosynthesis in animals. , 1989 .
[112] R. Carroll,et al. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: implications for patient follow-up. , 1989, The Journal of dermatologic surgery and oncology.
[113] W. Hicks,et al. Photodynamic therapy for cutaneous and subcutaneous malignant neoplasms. , 1989, Archives of surgery.
[114] N. Schoenfeld,et al. The heme biosynthetic pathway in lymphocytes of patients with malignant lymphoproliferative disorders. , 1988, Cancer letters.
[115] M. Waner,et al. Photodynamic Therapy for Multiple Skin Cancers , 1988, Plastic and reconstructive surgery.
[116] L. Leibovici,et al. Activity of porphobilinogen deaminase in peripheral blood mononuclear cells of patients with metastatic cancer , 1988, Cancer.
[117] J. D. Engel,et al. Structure, turnover, and heme-mediated suppression of the level of mRNA encoding rat liver delta-aminolevulinate synthase. , 1988, The Journal of biological chemistry.
[118] U. Muller-eberhard,et al. Pathophysiology of heme synthesis. , 1988, Seminars in hematology.
[119] P. Robinson,et al. Photodynamic therapy: a better treatment for widespread Bowen's disease , 1988, The British journal of dermatology.
[120] G. C. Ferreira,et al. Organization of the terminal two enzymes of the heme biosynthetic pathway. Orientation of protoporphyrinogen oxidase and evidence for a membrane complex. , 1988, The Journal of biological chemistry.
[121] R. Marks,et al. Incidence of non-melanocytic skin cancer treated in Australia , 1988, British medical journal.
[122] Ann Smith. Mechanisms of Toxicity of Photoactivated Artificial Porphyrins Role of Porphyrin‐Protein Interactions , 1987, Annals of the New York Academy of Sciences.
[123] J. McCaughan. OVERVIEW OF EXPERIENCES WITH PHOTODYNAMIC THERAPY FOR MALIGNANCY IN 192 PATIENTS , 1987, Photochemistry and photobiology.
[124] J Moan,et al. A comparison of different photosensitizing dyes with respect to uptake C3H-tumors and tissues of mice. , 1987, Cancer letters.
[125] T J Dougherty,et al. PHOTOSENSITIZERS: THERAPY AND DETECTION OF MALIGNANT TUMORS , 1987, Photochemistry and photobiology.
[126] J C Kennedy,et al. NON‐INVASIVE TECHNIQUE FOR OBTAINING FLUORESCENCE EXCITATION AND EMISSION SPECTRA IN VIVO , 1986, Photochemistry and photobiology.
[127] M. Berns,et al. Hematoporphyrin phototherapy of cancer. , 1986, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[128] J. Ratz,et al. Trends in the presentation and treatment of basal cell carcinomas. , 1986, The Journal of dermatologic surgery and oncology.
[129] E. Land,et al. Porphyrin localization and treatment of tumors , 1985, British Journal of Cancer.
[130] W. H. Elliott,et al. Complete nucleotide sequence of hepatic 5-aminolaevulinate synthase precursor. , 1985, European journal of biochemistry.
[131] D. Davies. Malignant skin conditions. , 1985, British medical journal.
[132] J Moan,et al. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells. , 1985, Cancer research.
[133] H. Dailey,et al. Differential interaction of porphyrins used in photoradiation therapy with ferrochelatase. , 1984, The Biochemical journal.
[134] R. Marchesini,et al. Laser Phototherapy following HpD Administration in Superficial Neoplastic Lesions , 1984, Tumori.
[135] D. Tse,et al. Hematoporphyrin derivative photoradiation therapy in managing nevoid basal-cell carcinoma syndrome. A preliminary report. , 1984, Archives of ophthalmology.
[136] K. Ingold,et al. Autoxidation of micelles and model membranes. Quantitative kinetic measurements can be made by using either water-soluble or lipid-soluble initiators with water-soluble or lipid-soluble chain-breaking antioxidants , 1984 .
[137] Marianne Krieg,et al. Self-sensitized photooxidation of protoporphyrin IX and related free-base porphyrins in natural and model membrane systems. Evidence for novel photooxidation pathways involving amino acids , 1984 .
[138] T J Dougherty,et al. Interaction of hyperthermia and photoradiation therapy. , 1984, Radiation research.
[139] P A Cowled,et al. COMPARISON OF THE EFFICACY OF PULSED AND CONTINUOUS‐WAVE RED LASER LIGHT IN INDUCTION OF PHOTOCYTOTOXICITY BY HAEMATOPORPHYRIN DERIVATIVE , 1984, Photochemistry and photobiology.
[140] N. Hayashi,et al. Inhibition by hemin of in vitro translocation of chicken liver delta-aminolevulinate synthase into mitochondria. , 1983, Biochemical and biophysical research communications.
[141] Anthony,et al. The characterization and submitochondrial localization of delta-aminolevulinic acid synthase and an associated amidase in rat liver mitochondria using an improved assay for both enzymes. , 1983, The Journal of biological chemistry.
[142] D. Whitten,et al. Photochemical reactivity in organized assemblies. 30. Self-sensitized photooxidation of protoporphyrin IX derivatives in aqueous surfactant solutions; product and mechanistic studies , 1982 .
[143] R. L. Carter,et al. TREATMENT OF HEAD-AND-NECK CANCER , 1982, The Lancet.
[144] David G. Whitten,et al. PHOTOOXIDATION AND SINGLET OXYGEN SENSITIZATION BY PROTOPORPHYRIN IX AND ITS PHOTOOXIDATION PRODUCTS , 1982 .
[145] T. Dougherty,et al. Photoradiation therapy for cutaneous and subcutaneous malignancies. , 1981, The Journal of investigative dermatology.
[146] N. Hayashi,et al. Translocation of delta-aminolevulinate synthase from the cytosol to the mitochondria and its regulation by hemin in the rat liver. , 1980, The Journal of biological chemistry.
[147] J. Bloomer,et al. Effect of endogenous heme generation on delta-aminolevulinic acid synthase activity in rat liver mitochondria. , 1979, The Journal of biological chemistry.
[148] S. Ida,et al. Excretion of porphyrins in urine and bile after the administration of delta-aminolevulinic acid. , 1978, The Journal of laboratory and clinical medicine.
[149] B. Grandchamp,et al. The mitochondrial localization of coproporphyrinogen III oxidase. , 1978, The Biochemical journal.
[150] J E Kaufman,et al. Photoradiation therapy for the treatment of malignant tumors. , 1978, Cancer research.
[151] G. Elder,et al. Evidence that the coproporphyrinogen oxidase activity of rat liver is situated in the intermembrane space of mitochondria. , 1978, The Biochemical journal.
[152] D. Whitten,et al. Photochemical reactions in organized monolayer assemblies. 8. Environmental effects on photochemical reactions: contrasts in the photooxidation behavior of protoporphyrin IX in solution, monolayer films, organized monolayer assemblies, and micelles , 1978 .
[153] N. Hayashi,et al. delta-Aminolevulinate synthetases in the liver cytosol fraction and mitochondria of mice treated with allylisopropylacetamide and 3,5-dicarbethoxyl-1,4-dihydrocollidine. , 1976, Journal of biochemistry.
[154] M. Moore,et al. The passage of delta-aminolaevulinic acid across the blood-brain barrier of the rat: effect of ethanol. , 1974, Biochemical pharmacology.
[155] U. Meyer,et al. Hereditary hepatic porphyrias. , 1973, Federation proceedings.
[156] H. Marver,et al. Intermittent acute porphyria--demonstration of a genetic defect in porphobilinogen metabolism. , 1972, The New England journal of medicine.
[157] H. Inhoffen,et al. Zur weiteren Kenntnis des Chlorophylls und des Hämins, XXX1) Photoprotoporphyrine und ihre Umwandlung in Spirographis- sowie Isospirographis-porphyrin2) , 1969 .
[158] P. Mustard,et al. The metabolism of (5-14C)delta-aminolaevulic acid in normal and porphyric human subjects. , 1968, Clinical science.
[159] L. Rasetti,et al. Porphyrin metabolism in human neoplastic tissues. , 1966, Panminerva medica.
[160] J. H. Dagg,et al. THE RELATIONSHIP OF LEAD POISONING TO ACUTE INTERMITTENT PORPHYRIA. , 1965, The Quarterly journal of medicine.
[161] R. Stoughton,et al. INFLUENCE OF DIMETHYLSULFOXIDE (DMSO) ON HUMAN PERCUTANEOUS ABSORPTION. , 1964, Archives of dermatology.
[162] A. Neuberger,et al. The metabolism of δ-aminolaevulic acid. 1. Normal pathways, studied with the aid of 15N , 1956 .
[163] D. Willoughby,et al. δ-AMINOLÆVULIC ACID AND PORPHYRIA , 1956 .
[164] D. Kessel,et al. Plasma levels of protoporphyrin IX in humans after oral administration of 5-aminolevulinic acid. , 1997, Journal of photochemistry and photobiology. B, Biology.
[165] M. Landthaler,et al. Photodynamic therapy with topical application of 5-aminolevulinic acid in the treatment of actinic keratoses: an initial clinical study. , 1996, Dermatology.
[166] M Motamedi,et al. Accumulation of porphyrins in plasma and tissues of dogs after delta-aminolevulinic acid administration: implications for photodynamic therapy. , 1996, Pharmacology.
[167] H Stepp,et al. Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence. , 1996, The Journal of urology.
[168] T. Cox,et al. Molecular regulation of heme biosynthesis in higher vertebrates. , 1995, Progress in nucleic acid research and molecular biology.
[169] L. Braathen,et al. Topical photodynamic therapy in verrucae. A pilot study. , 1995, Dermatology.
[170] C. Gomer,et al. Clinical and preclinical photodynamic therapy , 1995, Lasers in surgery and medicine.
[171] F. Cairnduff,et al. Photodynamic therapy of primary skin cancer: a review. , 1995, British journal of plastic surgery.
[172] E G Hahn,et al. Photodynamic therapy: successful destruction of gastrointestinal cancer after oral administration of aminolevulinic acid. , 1995, Gastrointestinal Endoscopy.
[173] H Stepp,et al. Fluorescence cystoscopy following intravesical instillation of 5-aminolevulinic acid: a new procedure with high sensitivity for detection of hardly visible urothelial neoplasias. , 1995, Urologia internationalis.
[174] J. Reguła,et al. Sensitization and photodynamic therapy (PDT) of gastrointestinal tumors with 5-aminolaevulinic acid (ALA) induced protoporphyrin IX (PPIX). A pilot study. , 1995, Neoplasma.
[175] M. Landthaler,et al. Unilateral localized basaliomatosis: treatment with topical photodynamic therapy after application of 5-aminolevulinic acid. , 1995, Dermatology.
[176] T. Dougherty. Photodynamic therapy. , 1993, Photochemistry and photobiology.
[177] H Kerl,et al. Topical photodynamic therapy with endogenous porphyrins after application of 5-aminolevulinic acid. An alternative treatment modality for solar keratoses, superficial squamous cell carcinomas, and basal cell carcinomas? , 1993, Journal of the American Academy of Dermatology.
[178] M W Berns,et al. Demonstration of synergistic effects of hyperthermia and photodynamic therapy using the chick chorioallantoic membrane model , 1992, Lasers in surgery and medicine.
[179] S. Marcus,et al. Global status of clinical photodynamic therapy: The registration process for a new therapy , 1992, Lasers in surgery and medicine.
[180] K. Svanberg,et al. Photodynamic therapy of human skin malignancies and laser-induced fluorescence diagnostics utilizing photofrin and delta-amino levulinic acid , 1992 .
[181] R. van Hillegersberg,et al. Photodynamic therapy for gastrointestinal tumors. , 1991, Scandinavian journal of gastroenterology. Supplement.
[182] Stanley J. Miller,et al. Biology of basal cell carcinoma (Part II). , 1991, Journal of the American Academy of Dermatology.
[183] Michele T. Cooper,et al. Cutaneous phototoxic occurrences in patients receiving Photofrin® , 1990, Lasers in surgery and medicine.
[184] D. Doiron,et al. Photodynamic Therapy for Nonmelanoma Skin Cancer , 1989, Facial plastic surgery : FPS.
[185] Michele T. Cooper,et al. Use of Photodynamic Therapy for the Treatment of Extensive Basal Cell Carcinomas , 1989, Facial plastic surgery : FPS.
[186] Kevin C. Smith,et al. Prospective study of cutaneous phototoxicity after systemic hematoporphyrin derivative , 1988, Lasers in surgery and medicine.
[187] S. Waldow,et al. Photodynamic therapy for treatment of malignant cutaneous lesions , 1987, Lasers in surgery and medicine.
[188] A. Gorchein,et al. delta-Aminolaevulinic acid in plasma, cerebrospinal fluid, saliva and erythrocytes: studies in normal, uraemic and porphyric subjects. , 1987, Clinical science.
[189] A. Luini,et al. Preliminary clinical studies with PDT by topical TPPS administration in neoplastic skin lesions , 1987, Lasers in surgery and medicine.
[190] T. Dougherty. Photosensitization of malignant tumors. , 1986, Seminars in surgical oncology.
[191] L. Goldman,et al. Application of photodynamic therapy in plastic surgery , 1986, Lasers in surgery and medicine.
[192] Cai Wei-ming,et al. Photodynamic therapy in the management of cancer: an analysis of 114 cases. , 1985, Advances in experimental medicine and biology.
[193] C. Gomer,et al. Porphyrin localization and treatment of tumors : proceedings of the Clayton Foundation International Symposium on Porphyrin Localization and Treatment of Tumors, Santa Barbara, California, April 24-28, 1983 , 1984 .
[194] J. Kennedy. HPD photoradiation therapy for cancer at Kingston and Hamilton. , 1983, Advances in experimental medicine and biology.
[195] R. Van De Velde,et al. [Disorders of porphyrin metabolism]. , 1973, Fortschritte der Medizin.